Advertisement

Topics

Boehringer Ingelheim Pharmaceuticals, Inc Company Profile

10:21 EDT 23rd June 2018 | BioPortfolio

Boehringer Ingelheim Corporation is the U.S. member of the Boehringer Ingelheim worldwide group of companies dedicated to the discovery, development, manufacture and marketing of innovative human and animal health care products.
It is the principal U.S. licensee of Boehringer Ingelheim GmbH, an international chemical and pharmaceutical firm that develops, produces and sells pharmaceuticals, veterinary medicines and biologicals, agricultural chemical products and fine, specialty chemicals in more than 45 companies around the world. Worldwide sales for the Boehringer Ingelheim group of companies were $10.2 billion in 2004. The world's largest privately held pharmaceutical enterprise, Boehringer Ingelheim GmbH employs over 36,000 people.

Boehringer Ingelheim Corporation is the parent of a group of U.S. companies that produce ethical pharmaceuticals, natural health products, veterinary products and fine chemicals. Collectively, the U.S. Boehringer Ingelheim companies employ more than 7,200 people.

Location

900 Ridgebury Road/P.O. Box 368
Ridgefield
Connecticut
6877
United States of America

Contact

Phone: (203) 798-9988
Fax: (800) 243-0127
Email: koconno4@rdg.boehringer-ingelheim.com


News Articles [810 Associated News Articles listed on BioPortfolio]

New Indication For Boehringer Ingelheim's Gilotrif Okayed By FDA

NewsThe FDA approved a supplemental New Drug Application for Boehringer Ingelheim's Gilotrif for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have non-...

Boehringer Ingelheim i Uniwersytet Vanderbilt poszerzają współpracę w celu opracowania ...

-- Trzecia współpraca firmy Boehringer Ingelheim i Uniwersytetu Vanderbilt INGELHEIM, Niemcy i NASHVILLE, Tennessee, 13 marca 2018 r. /PRNewswire/ -- Koncern Boehringer Ingelheim i Read more...

PRESSESPIEGEL/Unternehmen: BOEHRINGER INGELHEIM, THYSSENKRUPP, COMMERZBANK, K+S, LUFTHANSA, 50HERTZ, DEUTSCHE GLASFASER, CISCO, HYPOVEREINSBANK

Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires. BOEHRINGER INGELHEIM - Der Pharmakonzern Boehringer Ingelheim strukturiert seine Wirkstoffproduktion um. ...

Boehringer Ingelheim And Vanderbilt Univ. To Develop Novel Cancer Treatment

NewsBoehringer Ingelheim and Vanderbilt University will extend their existing collaboration to develop novel anti-cancer compounds, focusing on new chemical therapeutics.

Spoločnosť Boehringer Ingelheim a Univerzita Vanderbilt rozširujú svoje partnerstvo s ...

-- Ide už o tretiu spoluprácu medzi spoločnosťou Boehringer Ingelheim a Univerzitou Vanderbilt INGELHEIM, Nemecko a NASHVILLE, Tennessee, 13. marca 2018 /PRNewswire/ -- Spoločnosť Boehring...

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of its venture fund to €250M, which will allow it to expand its focus. Boehringer Ingelheim is a big...

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug

Boehringer Ingelheim has ditched its Alzheimer’s drug after it failed to meet the endpoints of a Phase II trial but will continue to look at it for the treatment of schizophrenia. One of German...

Boehringer Ingelheim Gives Up On Alzheimer's Drug

NewsThe company will shift the focus of its BI 409306 (PDE9 Inhibitor) from Alzheimer's disease to schizophrenia after Phase II topline results in Alzheimer's trials fail to meet efficacy endpoints.

Drugs and Medications [326 Associated Drugs and Medications listed on BioPortfolio]

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Dulcolax balance [Boehringer Ingelheim Pharmaceuticals Inc]

Boehringer-Ingelheim Consumer Health Care Products Dulcolax Balance® Drug Facts

Pradaxa [Boehringer Ingelheim Pharmaceuticals Inc.]

These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for o...

PubMed Articles [135 Associated PubMed Articles listed on BioPortfolio]

Boehringer-Ingelheim Satellite Symposium Choosing the Right Controller Therapy in Pediatric Patients with Asthma.

Donated chemical probes for open science.

Potent, selective and broadly characterized small molecule modulators of protein function (chemical probes) are powerful research reagents. The pharmaceutical industry has generated many high-quality ...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [230 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

The objective of this study is to evaluate the comparative bioavailability between Tamsulosin Hydrochloride 0.4 mg Capsules (Teva Pharmaceuticals USA) and Flomax® 0.4 mg Capsules (Boehrin...

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [1357 Associated Companies listed on BioPortfolio]

Boehringer Ingelheim Pharmaceuticals Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group ...

Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Corporation is the U.S. member of the Boehringer Ingelheim worldwide group of companies dedicated to the discovery, development, manufacture and marketing of innovative human and ...

Boehringer Ingelheim Pharmaceuticals, Inc.

Metabolism is one of Boehringer Ingelheim's core R&D areas and diabetes is one of the indications at the center of interest within the company's global research network. Boehringer Ingelheim is commit...

Boehringer Ingelheim Limited

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146...

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim erforscht, entwickelt, produziert und vermarktet Arzneimittel für Menschen in aller Welt.Mit 37.406 Mitarbeitern, die in 143 Gesellschaften auf allen Kontinenten beschäftigt sin...

More Information about "Boehringer Ingelheim Pharmaceuticals, Inc" on BioPortfolio

We have published hundreds of Boehringer Ingelheim Pharmaceuticals, Inc news stories on BioPortfolio along with dozens of Boehringer Ingelheim Pharmaceuticals, Inc Clinical Trials and PubMed Articles about Boehringer Ingelheim Pharmaceuticals, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boehringer Ingelheim Pharmaceuticals, Inc Companies in our database. You can also find out about relevant Boehringer Ingelheim Pharmaceuticals, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record